Published: 07/11/2002, Volume II2, No. 5830 Page 8
Cancer researchers have set up a strategic planning group to look at better ways of spending money on lung cancer research.The move follows a National Cancer Research Institute study which reveals that while accounting for 22 per cent of cancer mortality, lung cancer receives just 3 per cent of the£237m the UK spends on cancer research each year.'Lung cancer is not a particularly researchable or tractable disease to study, and it may be for these reasons lung cancer research is not particularly attractive to investigators, ' the study concludes. It also reveals that research spending generally matches the burden of disease.Breast, colorectal and prostate cancer research are three of the highest-funded cancer sites.But leukaemia, ovarian and cervical cancer spending is higher than the burden of disease.Leukaemia accounts for less than 3 per cent of all cancer mortality yet receives nearly 18 per cent of spend.
www. ncri. org. uk